MECHANISM OF ACTION
NAD⁺ (nicotinamide adenine dinucleotide) is a central coenzyme in cellular energy metabolism, serving as an electron carrier in the mitochondrial electron transport chain. Beyond energy production, NAD⁺ is a substrate for sirtuins (SIRT1–7 - longevity regulators), PARP (DNA repair enzymes), and CD38 (immune regulation). NAD⁺ levels decline ~50% per decade, contributing to reduced mitochondrial function, impaired DNA repair, and metabolic decline. Injectable NAD⁺ bypasses oral bioavailability limitations and achieves faster intracellular repletion vs. NMN or NR precursors - making it the preferred format in aggressive research protocols.
RESEARCH APPLICATIONS
- Mitochondrial bioenergetics restoration
- Sirtuin activation (SIRT1/3 longevity pathway)
- DNA repair enhancement (PARP substrate)
- Cellular energy metabolism and mitochondrial function research
- Cognitive clarity and neurological function research
RESEARCH HIGHLIGHTS
Sirtuin Activation and Longevity
2013NAD⁺ repletion in aged mice activated SIRT1 and SIRT3, restoring mitochondrial function, improving muscle endurance, and extending healthspan in multiple studies.
Ref: Gomes et al., Cell
DNA Repair via PARP
2016NAD⁺ depletion impairs PARP-mediated DNA repair; repletion restores repair capacity - particularly relevant in age-related genomic instability models.
Ref: Fang et al., Cell Metabolism
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
Lyophilised: 2–8°C, 12–24 months. Reconstituted: use within 24–48 hours at 2–8°C. Highly sensitive to light and oxidation - use amber vials, protect from air.
Regulatory Status
Not a registered pharmaceutical. Injectable vials supplied as research compound only. Not WADA prohibited.